STAGE IVB PROSTATE CANCER AJCC V8
Clinical trials for STAGE IVB PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVB PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVB PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early trial halted for new prostate cancer combo therapy
Disease control TerminatedThis early-stage study aimed to test the safety and initial effectiveness of a new immunotherapy drug, vudalimab, when added to standard hormone therapies for men with advanced prostate cancer that has spread but still responds to hormone treatment. The trial was designed to see …
Matched conditions: STAGE IVB PROSTATE CANCER AJCC V8
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Early-Stage trial halted after testing drug duo for tough prostate cancer
Disease control TerminatedThis early-stage trial aimed to see if adding a new oral drug (decitabine/cedazuridine) to a standard prostate cancer drug (enzalutamide) was safe and could help overcome treatment resistance. It involved 8 men with advanced prostate cancer that had spread and stopped responding …
Matched conditions: STAGE IVB PROSTATE CANCER AJCC V8
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Drug trial halted early for advanced prostate cancer
Disease control TerminatedThis study tested whether a drug called erdafitinib could help control advanced prostate cancer that had stopped responding to standard hormone treatments and spread to the bones. It involved 11 men and aimed to see if the drug could slow cancer growth and reduce bone-related mar…
Matched conditions: STAGE IVB PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Targeted drug duo tested for Tough-to-Treat prostate cancer
Disease control TerminatedThis study tested whether combining two drugs, apalutamide and abiraterone acetate, could better control advanced prostate cancer that had spread and stopped responding to standard hormone therapy. It aimed to see if this combination could slow the cancer's growth in men whose tu…
Matched conditions: STAGE IVB PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Targeted radiation tested to ease agony of cancer in bones
Symptom relief TerminatedThis study tested an experimental radioactive drug designed to target and treat cancer that has spread to the bones from prostate cancer. The main goal was to see if the treatment could provide lasting relief from the severe bone pain caused by these metastases. The trial was ter…
Matched conditions: STAGE IVB PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
Study maps genetic risks in advanced prostate cancer patients
Knowledge-focused TerminatedThis study offered genetic testing to 799 men whose prostate cancer had spread to other parts of the body. Researchers tested saliva samples for inherited cancer-risk genes to understand how common these genetic changes are in this patient group. The study also explored participa…
Matched conditions: STAGE IVB PROSTATE CANCER AJCC V8
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC